Year |
Citation |
Score |
2022 |
Zhang L, Geng X, Wang F, Tang J, Ichida Y, Sharma A, Jin S, Chen M, Tang M, Pozo FM, Wang W, Wang J, Wozniak M, Guo X, Miyagi M, et al. 53BP1 regulates heterochromatin through liquid phase separation. Nature Communications. 13: 360. PMID 35042897 DOI: 10.1038/s41467-022-28019-y |
0.334 |
|
2021 |
Sharma A, Almasan A. Autophagy and PTEN in DNA damage-induced senescence. Advances in Cancer Research. 150: 249-284. PMID 33858598 DOI: 10.1016/bs.acr.2021.01.006 |
0.705 |
|
2020 |
Sharma A, Almasan A. USP14 Regulates DNA Damage Response and Is a Target for Radiosensitization in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 21. PMID 32887472 DOI: 10.3390/Ijms21176383 |
0.751 |
|
2019 |
Kapoor I, Li Y, Sharma A, Zhu H, Bodo J, Xu W, Hsi ED, Hill BT, Almasan A. Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies. Cell Death & Disease. 10: 924. PMID 31801949 DOI: 10.1038/S41419-019-2158-0 |
0.751 |
|
2019 |
Sharma A, Alswillah T, Kapoor I, Debjani P, Willard B, Summers MK, Gong Z, Almasan A. USP14 is a deubiquitinase for Ku70 and critical determinant of non-homologous end joining repair in autophagy and PTEN-deficient cells. Nucleic Acids Research. PMID 31740976 DOI: 10.1093/Nar/Gkz1103 |
0.796 |
|
2019 |
La Belle Flynn A, Calhoun BC, Sharma A, Chang JC, Almasan A, Schiemann WP. Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression. Nature Communications. 10: 3668. PMID 31413316 DOI: 10.1038/S41467-019-11640-9 |
0.709 |
|
2018 |
Sharma A, Almasan A. Autophagy as a mechanism of Apo2L/TRAIL resistance. Cancer Biology & Therapy. 1-8. PMID 30067424 DOI: 10.1080/15384047.2018.1472191 |
0.763 |
|
2018 |
Sharma A, Alswillah T, Singh K, Chatterjee P, Willard B, Venere M, Summers MK, Almasan A. USP14 regulates DNA damage repair by targeting RNF168-dependent ubiquitination. Autophagy. PMID 29995557 DOI: 10.1080/15548627.2018.1496877 |
0.785 |
|
2014 |
Sharma A, Janocha AJ, Hill BT, Smith MR, Erzurum SC, Almasan A. Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells. Molecular Cancer Research : McR. 12: 1205-15. PMID 25061101 DOI: 10.1158/1541-7786.Mcr-14-0124 |
0.754 |
|
2014 |
Singh K, Sharma A, Mir MC, Drazba JA, Heston WD, Magi-Galluzzi C, Hansel D, Rubin BP, Klein EA, Almasan A. Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin). Molecular Cancer. 13: 70. PMID 24655592 DOI: 10.1186/1476-4598-13-70 |
0.753 |
|
2013 |
Bodo J, Zhao X, Sharma A, Hill BT, Portell CA, Lannutti BJ, Almasan A, Hsi ED. The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways. British Journal of Haematology. 163: 72-80. PMID 23889282 DOI: 10.1111/Bjh.12498 |
0.752 |
|
2013 |
Sharma A, Singh K, Mazumder S, Hill BT, Kalaycio M, Almasan A. BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells. Cell Death & Disease. 4: e628. PMID 23681223 DOI: 10.1038/Cddis.2013.155 |
0.763 |
|
2013 |
Chatterjee P, Choudhary GS, Sharma A, Singh K, Heston WD, Ciezki J, Klein EA, Almasan A. PARP inhibition sensitizes to low dose-rate radiation TMPRSS2-ERG fusion gene-expressing and PTEN-deficient prostate cancer cells. Plos One. 8: e60408. PMID 23565244 DOI: 10.1371/Journal.Pone.0060408 |
0.762 |
|
2013 |
Chatterjee P, Choudhary GS, Sharma A, Singh K, Heston WD, Ciezki J, Klein EA, Almasan A. Combination of rucaparib with radiation increases χH2AX and 53BP1 foci leading to persistent DNA damage. Plos One. DOI: 10.1371/Journal.Pone.0060408.G003 |
0.745 |
|
2012 |
Sharma A, Singh K, Almasan A. Histone H2AX phosphorylation: a marker for DNA damage. Methods in Molecular Biology (Clifton, N.J.). 920: 613-26. PMID 22941631 DOI: 10.1007/978-1-61779-998-3_40 |
0.755 |
|
Show low-probability matches. |